Delivery Order 75N91018D00020-75N91020F00050

Award Date 2/23/20
Potential Completion Date 3/21/25
Potential Value $858K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Detroit, MI 48202, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
4
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $23,563,700.00 delivery order contract awarded to Henry Ford Health System by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract is a task order under the larger "Cancer Study Cohort Recruitment" Indefinite Delivery, Indefinite Quantity (IDIQ) master agreement. The contract has no set-aside designation. Under this task order, Henry Ford Health System will provide services related to the CONNECT initiative,...
This is a task order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Henry Ford Health System, a non-profit integrated healthcare provider located in Detroit, Michigan, to prepare for and conduct a cancer study cohort recruitment. The task order, which has a potential value of $20,054,873.00, was awarded on August 1, 2020 and is scheduled for completion on June 30, 2025. The task order was issued under a larger...
This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to Henry Ford Health System, a non-profit healthcare provider and research organization based in Detroit, Michigan. The contract is part of the NCI Cancer Genome Atlas Program Tissue Purchase master indefinite delivery/indefinite quantity (IDIQ) contract, and provides $235,016.09 to acquire tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program. The contract has no...
This is a firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services, to Henry Ford Health System, a non-profit healthcare provider and research organization in Detroit, Michigan. The contract is for $87,000.26 to provide Computed Tomography (CT) and Echocardiography (ECHO) analysis services in support of the Lampoon Protocol, with a performance period ending on July 2, 2020. This contract does...
This is a $547,860 delivery order contract awarded by the National Cancer Institute (NCI) of the Department of Health and Human Services (HHS) to The Institute for Cancer Research, a non-profit research organization. The contract is part of the Preclinical Efficacy and Intermediate Endpoint Biomarkers indefinite delivery vehicle, which supports the PREVENT Cancer Preclinical Drug Development Program. Under this 5-year IDIQ, The Institute for Cancer Research provides preclinical efficacy...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $215,032.00 cost-plus-fixed-fee delivery order contract to the Institute for Defense Analyses (IDA), a nonprofit research organization. The contract is for services related to electronic data interchange (EDI) for the National Cancer Clinical Trials Network (NCTN), the National Cancer Institute Central Institutional Review Board (NCIRB), and the Subscription Services Center (SSC). The...
This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Wayne State University in Detroit, Michigan. The contract, valued at $149,029.00, is for the collection and integration of patient-generated health data to enhance cancer registry data collected by the Surveillance, Epidemiology, and End Results (SEER) program. The work is to be performed from September 19, 2016 to...
This is a federal contract award from the Department of Health and Human Services National Institutes of Health National Cancer Institute to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract, valued at $67,882,919.00, is a cost-plus-fixed-fee delivery order for the PDX PANELS FROM COMMON TUMORS project. The work is to be performed at the Fort Detrick facility in Maryland and has a completion date of September 25, 2027. The contract does not have a set-aside...
This is a delivery order awarded by the National Institutes of Health (NIH) National Cancer Institute (NCI) to the Institute for Defense Analyses (IDA), a nonprofit Federally Funded Research and Development Center (FFRDC). The $170,000.00 task order is for the evaluation of NCI's Informatics Technology for Cancer Research (ITCR) program. IDA will provide analysis and assessment services to support the Cancer Biology and Genomics Section of the NCI's Center for Biomedical Informatics and...
This is a delivery order contract awarded by the National Cancer Institute (NCI), an institute within the Department of Health and Human Services (HHS), to the Fred Hutchinson Cancer Research Center (Fred Hutch) for core infrastructure support for the Surveillance, Epidemiology, and End Results (SEER) program. The period of performance is from May 1, 2015 to April 30, 2016, with a ceiling value of $12,947,683. This delivery order is not set aside. The contract includes several subcontract awards...

This is a delivery order contract awarded by the National Cancer Institute, a civilian federal agency, to Henry Ford Health System, a non-profit integrated healthcare provider and research organization. The contract, valued at $857,850.52, is for continued infrastructure setup and is part of a larger indefinite delivery, indefinite quantity (IDIQ) master agreement focused on cancer study cohort recruitment. The contract does not have a set-aside designation. Through this task order, Henry Ford Health System will leverage its network of hospitals, medical centers, and research facilities to perform critical research and services in support of the National Cancer Institute's medical research initiatives.

Generated 4/21/25, 3:40 AM